Biowraptor's peptide-based biologics stabilization technology

Overview

BioWraptor has developed a revolutionary technology designed to stabilize biologics using a peptide-based formulation. This innovative approach offers significant advantages, including lower manufacturing costs, an extended shelf life, and an eco-friendly process. By eliminating the need for drying instruments and cold chain logistics, BioWraptor's solution simplifies the stabilization of sensitive biologics. The technology employs a smart space-filling formulation that forms an adaptive biomimetic environment, protecting biologics from environmental variations such as humidity, temperature, and light.

Technical specifications

BioWraptor's solution utilizes designed short peptides that engage in reversible and dynamic interactions to stabilize biologics while maintaining their native functionality. The process is straightforward: mix BioWraptor with the biologic and let it air-dry. Peptides form robust microspheres around the biologic, which readily dissolve in water when needed. This universal solution adapts to various biologics, including vitamins, dyes, and proteins, eliminating the need for new processes with each component. The technology has shown efficacy in encapsulating and preserving a range of biomolecules, offering protection in both dry and solution states over extended periods.

Technology readiness level

The technology is currently at TRL 3, with initial proof-of-concept findings demonstrating the efficacy of the peptide-based encapsulation method. Future validation efforts include broad-spectrum encapsulation testing, performance evaluation under real-world conditions, stability testing under varying environmental conditions, and a cost-benefit analysis compared to traditional methods.